Re: Zenith presents at BIO Investor Forum Oct 17th

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith presents at BIO Investor Forum Oct 17th

in response to

Zenith presents at BIO Investor Forum Oct 17th

BearDownAZ

posted on Oct 17, 2018 10:19PM

Looks like Mr. Ken Lebioda and Dr. Sanjay Lakhotia gave the presentations today for Resverlogix and Zenith, respectively (according to the company presentation schedule on the BIO Investor Forum web site). I don't see either slide deck on the company web pages though. Perhaps too close to the AGM just a month prior to expect anything new.